Nancy Dahms

Medical College of Wisconsin — United States

Medicine · Health Sciences

36h-index5.0kcitations122works7.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lysosomal Storage Disorders Research(53), Glycosylation and Glycoproteins Research(51), Cellular transport and secretion(36), Carbohydrate Chemistry and Synthesis(30), Calcium signaling and nucleotide metabolism(14)

Publications122 total

Glycosphingolipids and their impact on platelet activity in a murine model of fabry disease
Scientific Reports·2024· 2 citedOpen Access
Lysosomal enzyme binding to the cation-independent mannose 6-phosphate receptor is regulated allosterically by insulin-like growth factor 2
Scientific Reports·2024· 9 citedOpen Access
Fabry disease Schwann cells release p11 to induce sensory neuron hyperactivity
JCI Insight·2024· 11 citedOpen Access
Schwann cell release of p11 induces sensory neuron hyperactivity in Fabry disease
2023· 1 citedOpen Access
Multiple Domains of Staphylococcal Superantigen-like Protein 11 (SSL11) Contribute to Neutrophil Inhibition
Biochemistry·2022· 10 citedOpen Access
Platelet and myeloid cell phenotypes in a rat model of Fabry disease
The FASEB Journal·2021· 5 citedOpen Access
Tissue plasminogen activator is a ligand of cation-independent mannose 6-phosphate receptor and consists of glycoforms that contain mannose 6-phosphate
Scientific Reports·2021· 4 citedOpen Access
Allosteric regulation of lysosomal enzyme recognition by the cation-independent mannose 6-phosphate receptor
Communications Biology·2020· 34 citedOpen Access
Allosteric regulation of lysosomal enzyme recognition by the cation-independent mannose 6-phosphate receptor
2020· 4 citedOpen Access
Platelet and myeloid cell phenotypes in a rat model of Fabry disease
Molecular Genetics and Metabolism·2020
A novel AAV capsid with improved tropism to heart, kidney and PNS for treatment of Fabry disease
Molecular Genetics and Metabolism·2020
Progressive hearing loss in the α-galactosidase A deficient rat model of Fabry disease
Molecular Genetics and Metabolism·2020
Progress in the understanding and treatment of Fabry disease
Biochimica et Biophysica Acta (BBA) - General Subjects·2019· 104 citedOpen Access
Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
Scientific Reports·2019· 11 citedOpen Access
N-terminal 5 domains of IGFIIR
2019
α‐Galactosidase A‐deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease
The FASEB Journal·2018· 33 citedOpen Access
830 Fabry rat skin findings demonstrate potential roles of inflammation and lipoatrophy in Fabry disease
Journal of Investigative Dermatology·2018
Neuropathic pain in a Fabry disease rat model
JCI Insight·2018· 69 citedOpen Access
Mechanical sensitization indicates neuropathic allodynia in a rat model of fabry disease
Journal of Pain·2018· 3 cited
Systemic mRNA therapy for the treatment of Fabry disease: Preclinical studies in GLA-deficient mice and rats, and wild-typenon-human primates
Molecular Genetics and Metabolism·2018
page 1 of 7Next →

Frequent Co-authors

Linda J. Olson(14), Stuart Kornfeld(10), Jung‐Ja P. Kim(8), Peter Lobel(4), Richard N. Bohnsack(4), Michael K. Hancock(4), Bellur Seetharam(4), James J. Miller(3), Gerald W. Hart(3), Mariko Kudo(3), Russell Gotschall(3), William M. Canfield(3), Richard D. Cummings(3), David F. Smith(3), Michael Tiemeyer(3), Mary A. Brzycki-Wessell(3), Francis C. Peterson(3), Alicia C. Castonguay(3), Shakuntla Seetharam(3), Patricia G. Marron‐Terada(3)